RESERVE OR RETENTION SAMPLES PRESENTED BY N. SRIKANTH 1.

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

WHO - PSM Documentation – Part 2 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm.
MANUFACTURING DOCUMENTS.
GMP Document and Record Retention
Good Manufacturing Practices Guilin, PRC Dr AJ van Zyl for Quality Assurance and Safety: Medicines Medicines Policy and Standards Health Technology and.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
Module 12 – part 2 | Slide 1 of 35 January 2006 Basic Principles of GMP Documentation Part 2 15.
All You Never Wanted to Know About GLP and GMP
Quality control of raw materials In-process control
MANUFACTURING OF API AND INTERMEDIATES
FIELD COMPLIANCE UPDATE CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
Reference, Retention and Reserve Samples
Distributed Manufacturing via the SNM Multicenter FLT IND Part II SNM Midwinter Clinical Trials Network Albuquerque, New Mexico February 2, 2010 Sally.
VALIDATION OF RAW MATERIALS
Regulatory requirements on Medicine Stability Guidelines relevant for Stability testing Sultan Ghani.
Good Laboratory Practices
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Documentation –Part 2 Basic Principles of GMP Pharmaceutical Quality,
World Health Organization
Basic Principles of GMP
Presentation #18 Drug Recalls Drug recalls must be reviewed by the Department and forwarded to the appropriate manager at the LHD. The manager shall.
A Basic Overview of the US FDA’s Regulations for Regulatory Compliance
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
Important informations
Aloe Vera of America: A Quality IASC-Certified Producer of Aloe Vera Presented by Walt Jones.
Meeting for EU Generic Manufacturers and EU MA holders for generic medicines, Copenhagen, 26 November 2009 Generics approved by stringent regulatory authorities:
Tad and Terry Legal Issues in ILP. 28 CFR Part 23 The federal rule that governs or provides guidance for these issues. § 23.3 Applicability: These policy.
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
WHO - PSM Materials Pharmaceutical Quality, Good manufacturing Practice & Bioequivalence Kiev, Ukraine October 2005 Maija Hietava M.Sci.Pharm Quality.
Inventory Management: Distribution, ICS, LMIS Technical Briefing Seminar in Procurement and Supply Management for HIV, TB and Malaria Copenhagen, 1 February.
Reading A Medication Label. Trade Name ( ) Always capitalized ® or ™ will follow the name  Name given by the United State Pharmacopeia- National Formulary.
Master Formula And Batch MaNUFACTURING Record
Basic Principles of GMP
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
IP Accountability in Outpatient Clinical Trials
Module 14Slide 1 of 23 WHO - EDM Basic Principles of GMP Active Pharmaceutical Ingredients Part Three, 18.
Module 12 - part 2Slide 1 of 23 WHO - EDM Basic Principles of GMP Documentation Part 2 Part One, 14.
GOOD DOCUMENTATION PRACTICES (GDP)
Thanks for giving me an opportunity to share with you our process for controlling media and other supplies. Disclaimer: We are not yet accredited to ISO.
Quality Control significance in pharmaceutical industry
Regulatory Labeling and Marketing. Which ones are involved in label design and control? Manufacturing Manufacturing Quality Assurance Quality Assurance.
Just in Time Labelling in the EEA Duncan J Donald VP Quality Europe Yourway transport Biopharma Services.
IP Accountability in Outpatient Clinical Trials Jessica Rinaldi, CCRP Farber Institute for Neurosciences.
 TATA CONSULTANCY SERVICES MM - Inventory management.
“Good Manufacturing Practices”
LABORATORY SAMPLES AND CONTRACT MANAGEMENT
TASKS OF QUALITY CONTROL LAB. Eli.S M.Sc, Lect. No. 6.
Basic Principles of GMP
DOCUMENT AND DATA CONTROL
Chapter 14 Inventory Control.
GOOD MANUFACTURING PRACTICE FOR BIOPROCESS ENGINEERING (ERT 425)
Quality Control and Assurance
EU draft Community Guide to Good Hygiene Practice for the use of animal feed in primary production « Workshop on feed safety, marketing and use of feed.
DISTRIBUTION AND DISTRIBUTION RECORDS
Basic Principles of GMP
Documentation –Part 2 Basic Principles of GMP Pharmaceutical Quality,
PHARMACEUTICAL QUALITY
WHO Technical Report Series, No. 953, 2009
Regulatory Guide 1.21 – Reporting of LLW shipped
Lecture LOs a) Appreciate the (complexity) course, in general..
GSP for pharmaceutical products
Certification system for prepackages
RECORDS AND INFORMATION
Good Laboratory Practices
World Health Organization
Lesson 6 Good Production Practice #6
Complaints and Recalls
Basic Principles of GMP
Quality control Lecture 1.
Radiopharmaceutical Production
Presentation transcript:

RESERVE OR RETENTION SAMPLES PRESENTED BY N. SRIKANTH 1

Common Names  Reserve samples  Retention samples  Control samples  Reference samples 2

Definitions  Reference samples  Starting material or finished product or packing material which can be stored for the future analysis if the need arises during the shelf life of the Batch concerned.  Retention sample:  Sample collected from the batch. These are useful for referring the packing style, batch number, Mfg date, Exp date, Patient leaf let or any other relevant information for the batch concerned during shelf life. 3

Sample size and analysis  Samples shall be collected for Starting material, Finished Products and packing materials for each and every batch of the manufacturing.  Samples shall be Collected in such a way that the quantity minimum required for two times full analysis as per compendial analysis or In-house product specification. 4

Storage  Active pharmaceutical ingredient (API) and finished product samples shall be stored at their label storage conditions and packing similar to marketed product.  The API and finished products shall be stored in its primary packing material. 5

Physical Observation of the samples  Visually inspect the samples for every six months. Record the observations in the register. 6

Retention period  Finished Products reserve samples shall be maintained at least for one year after Expiry date (EudraLex, Volume-4, Annexe 19/21 CFR ). Samples of starting material Retain for at least two years after the release of product, it may be shorted if the material shelf life is shorter.(EudraLex, Volume-4, Annexe 19).  For an active ingredient in a drug product the samples shall be retained for 1 year after the expiration date of the last lot of the drug product containing the active ingredient or 3 years from the date of distribution which ever is longer(21 CFR Reserve samples). 7

Sample Deterioration  Any deterioration observed during inspection or analysis the batch shall be investigated( 21 CFR (Production record review). 8

Destruction  Destroy the samples after retention period. Destruction shall comply as per the regulatory requirements of their country( Solid waste disposal or liquid waster disposal etc..) 9

Records  Reserve samples inward register, samples destruction record, Physical observation record shall be maintained by Quality Control department. These registers shall be maintained for both API and Finished Products.  Reserve samples inward register may consists of S.No, Date, Name of the Product, batch No, Mfg Date, Exp Date, Qty of samples withdrawn, done by (IPQA), checked by (QC), Qty. of sample Withdrawn, done by(QC),Checked by(QC) Qty Left and remarks. 10

Records  Samples destruction record consists of Date, Name of the sample, batch No, Mfg. Date, Expiry date, Qty, Destruction supervised by(QC) and Checked by (QA) and remarks.  Physical observation record consists of the Date, name of the samples, batch No, Mfg date, Expiry date, Observation, remarks. 11